or
forgot password

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies


N/A
18 Years
N/A
Not Enrolling
Both
Bladder Cancer, Skin Cancers, Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)

Thank you

Trial Information

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies


Inclusion Criteria:

N/A. We will recruit all non-melanoma skin and bladder cancer patients
that are recommended for surgical removal of tumor tissues. This includes patients from
all ages, gender and ethnicity background. Our sample collection criteria based on the
tumor size of individual (e.g. tumor samples will only be collected if it will not affect
the pathological diagnosis or treatment procedures of patients).

Exclusion Criteria:N/A

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Measurement of cancer stem cells (CSCs)

Outcome Time Frame:

The current study does not include the active involvement of patients. Our study involves the collection of tumor samples from patients after surgical procedures.

Safety Issue:

No

Principal Investigator

Irving L. Weissman M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

BLDR0011

NCT ID:

NCT01060319

Start Date:

December 2013

Completion Date:

December 2014

Related Keywords:

  • Bladder Cancer
  • Skin Cancers
  • Bladder (Urothelial, Transitional Cell) Cancer
  • Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)
  • Urinary Bladder Neoplasms
  • Skin Neoplasms

Name

Location
Stanford University School of Medicine Stanford, California  94305-5317